Drug-induced erythroderma (Q43856): Difference between revisions

From determinar.ia.br - Determine suas informações
Changed an Item
Changed an Item
 
(2 intermediate revisions by the same user not shown)
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: L27.0 / rank
 
Normal rank

Latest revision as of 11:02, 13 August 2026

Erythroderma (defined as erythema and scaling involving at least 90% of the skin surface) which is attributable to drug administration but which cannot be more precisely categorized, thus excluding more specific severe cutaneous adverse reactions to drugs reaction patterns such as DRESS syndrome, acute generalised exanthematous pustulosis (AGEP) and toxic epidermal necrolysis. Many drugs have been implicated.
Language Label Description Also known as
default for all languages
EH64
    English
    Drug-induced erythroderma
    Erythroderma (defined as erythema and scaling involving at least 90% of the skin surface) which is attributable to drug administration but which cannot be more precisely categorized, thus excluding more specific severe cutaneous adverse reactions to drugs reaction patterns such as DRESS syndrome, acute generalised exanthematous pustulosis (AGEP) and toxic epidermal necrolysis. Many drugs have been implicated.

      Statements

      CID11:EH64
      0 references
      dki-india-EH64
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references